CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Open-market sale See Remarks sold 3,228 shares at $13.45 ($43,417)
- 4 Planned sale See Remarks sold 9,375 shares at an average $16.03 ($150,260)
- 4 Open-market buy 10% owner bought 1,470,000 shares at $19.00 ($27,930,000)
- 4 Planned sale Director sold 42,000 shares at $15.00 ($630,000)
- 4 Planned sale Director sold 14,000 shares at an average $13.50 ($189,000)
- 4 Planned sale Director sold 93,445 shares at an average $14.65 ($1,369,324)
- 4 Planned sale Director sold 134,218 shares at an average $13.58 ($1,823,159)
- 4 Planned sale Director sold 20,000 shares at an average $13.47 ($269,461)
- 4 Planned sale See Remarks sold 441,031 shares at an average $14.57 ($6,427,085)
- 4 Planned sale Chief Financial Officer sold 260,036 shares at an average $15.78 ($4,103,979)
- 4 Planned sale Director sold 16,115 shares at an average $13.48 ($217,297)
- 4 Planned sale Director sold 16,115 shares at $6.79 ($109,421)
- 4 Open-market buy Director bought 1,000 shares at $6.69 ($6,688)
- 4 Planned sale Director sold 10,000 shares at $10.00 ($100,000)
- 4 Planned sale President and CEO sold 217,351 shares at $10.10 ($2,194,810)
- 4 Planned sale Director sold 21,000 shares at $9.25 ($194,250)
- 4 Grant or award Director acquired 12,700 shares (grant or award)
- 4 Grant or award Director acquired 12,700 shares (grant or award)
- 4 Grant or award Director acquired 25,400 shares (grant or award)
- 4 Grant or award Director acquired 12,700 shares (grant or award)
Page 2 of 14 · 274 filings